SG biotech startup Mirxes files for Hong Kong IPO after $50m Series D funding

SG biotech startup Mirxes files for Hong Kong IPO after $50m Series D funding

Mars W. Mosqueda Jr.

26 July, 2023

Edited by: Padma Priya

Printed by Unregistered user on Sat, 26 Jul 2025 14:44:16 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Biotech firm Mirxes said to be looking at raising up to $200m in Singapore IPO

SG’s MiRXES raises $87m in Series C round to expand product pipeline

Read more from Singapore

Beyond the Buyout: India exits show capital is flowing back to investors

Blackstone nears $8b for latest Asia buyout fund